INTENSITY THERAPEUTICS, INC. - INTS
Sector:
Healthcare
· Industry:
Biological Products, (No Diagnostic Substances)
Website:
No information yet
· Social:
No information yet
Company profile
Powered by TradingView
Quarter snapshot
Latest / Compare
Q1 2026
· Q4 2025
Value (USD)
Total reported value ($000)
$1.093M
QoQ value delta ($000)
-$476K
(-30.34%)
Implied price effect (QoQ)
+243.32%
Shares
Total shares
795,187
QoQ shares delta
-3,123,820
(-79.71%)
Total shares held by funds (by quarter)
Market chart (INTS)
Powered by TradingView
Interactive chart by
TradingView.
Top holders (Q1 2026)
Top 25 only
Full list
Partial Q1 2026 data: 12 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.
| Manager | Value ($000) | Shares | % of 13F |
|---|---|---|---|
| VANGUARD GROUP INC | 266 | 649,084 | 0.0% |
| GEODE CAPITAL MANAGEMENT, LLC | 152 | 26,019 | 0.0% |
| SAPIENT CAPITAL LLC | 152 | 26,006 | 0.0% |
| NANO CAP NEW MILLENNIUM GROWTH FUND L P | 147 | 25,000 | 0.14% |
| Rothschild Wealth LLC | 136 | 23,294 | 0.01% |
| VANGUARD CAPITAL MANAGEMENT LLC | 99 | 16,841 | 0.0% |
| Mesirow Financial Investment Management, Inc. | 83 | 14,118 | 0.0% |
| VANGUARD FIDUCIARY TRUST CO | 53 | 9,121 | 0.0% |
| CIBC Private Wealth Group LLC | 2 | 5,025 | 0.0% |
| UBS Group AG | 1 | 192 | 0.0% |
| WELLS FARGO & COMPANY/MN | 1 | 200 | 0.0% |
| OSAIC HOLDINGS, INC. | 1 | 200 | 0.0% |
| MORGAN STANLEY | 0 | 20 | 0.0% |
| Tower Research Capital LLC (TRC) | 0 | 67 | 0.0% |